Literature DB >> 23624935

BRCA1 is a negative modulator of the PRC2 complex.

Lan Wang1, Xianzhuo Zeng, Shuai Chen, Liya Ding, Jian Zhong, Jonathan C Zhao, Liguo Wang, Aaron Sarver, Antonius Koller, Jizu Zhi, Yupo Ma, Jindan Yu, Junjie Chen, Haojie Huang.   

Abstract

The Polycomb-repressive complex 2 (PRC2) is important for maintenance of stem cell pluripotency and suppression of cell differentiation by promoting histone H3 lysine 27 trimethylation (H3K27me3) and transcriptional repression of differentiation genes. Here we show that the tumour-suppressor protein BRCA1 interacts with the Polycomb protein EZH2 in mouse embryonic stem (ES) and human breast cancer cells. The BRCA1-binding region in EZH2 overlaps with the noncoding RNA (ncRNA)-binding domain, and BRCA1 expression inhibits the binding of EZH2 to the HOTAIR ncRNA. Decreased expression of BRCA1 causes genome-wide EZH2 re-targeting and elevates H3K27me3 levels at PRC2 target loci in both mouse ES and human breast cancer cells. BRCA1 deficiency blocks ES cell differentiation and enhances breast cancer migration and invasion in an EZH2-dependent manner. These results reveal that BRCA1 is a key negative modulator of PRC2 and that loss of BRCA1 inhibits ES cell differentiation and enhances an aggressive breast cancer phenotype by affecting PRC2 function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624935      PMCID: PMC3671259          DOI: 10.1038/emboj.2013.95

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  83 in total

1.  ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency.

Authors:  Carlos F Pereira; Francesco M Piccolo; Tomomi Tsubouchi; Stephan Sauer; Natalie K Ryan; Ludovica Bruno; David Landeira; Joana Santos; Ana Banito; Jesus Gil; Haruhiko Koseki; Matthias Merkenschlager; Amanda G Fisher
Journal:  Cell Stem Cell       Date:  2010-06-04       Impact factor: 24.633

2.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.

Authors:  Penney M Gilbert; Janna K Mouw; Meredith A Unger; Johnathon N Lakins; Mawuse K Gbegnon; Virginia B Clemmer; Miriam Benezra; Jonathan D Licht; Nancy J Boudreau; Kelvin K C Tsai; Alana L Welm; Michael D Feldman; Barbara L Weber; Valerie M Weaver
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

3.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.

Authors:  Syuzo Kaneko; Gang Li; Jinsook Son; Chong-Feng Xu; Raphael Margueron; Thomas A Neubert; Danny Reinberg
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

4.  Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.

Authors:  Kyoko L Yap; Side Li; Ana M Muñoz-Cabello; Selina Raguz; Lei Zeng; Shiraz Mujtaba; Jesús Gil; Martin J Walsh; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

5.  Genome-wide identification of polycomb-associated RNAs by RIP-seq.

Authors:  Jing Zhao; Toshiro K Ohsumi; Johnny T Kung; Yuya Ogawa; Daniel J Grau; Kavitha Sarma; Ji Joon Song; Robert E Kingston; Mark Borowsky; Jeannie T Lee
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

6.  Genome-wide analysis of DNA binding and transcriptional regulation by the mammalian Doublesex homolog DMRT1 in the juvenile testis.

Authors:  Mark W Murphy; Aaron L Sarver; Daren Rice; Katerina Hatzi; Kenny Ye; Ari Melnick; Leslie L Heckert; David Zarkower; Vivian J Bardwell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-07       Impact factor: 11.205

7.  CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.

Authors:  Yongkun Wei; Ya-Huey Chen; Long-Yuan Li; Jingyu Lang; Su-Peng Yeh; Bin Shi; Cheng-Chieh Yang; Jer-Yen Yang; Chun-Yi Lin; Chien-Chen Lai; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2010-12-05       Impact factor: 28.824

8.  Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate.

Authors:  Theresa A Proia; Patricia J Keller; Piyush B Gupta; Ina Klebba; Ainsley D Jones; Maja Sedic; Hannah Gilmore; Nadine Tung; Stephen P Naber; Stuart Schnitt; Eric S Lander; Charlotte Kuperwasser
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

9.  Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators.

Authors:  David Landeira; Stephan Sauer; Raymond Poot; Maria Dvorkina; Luca Mazzarella; Helle F Jørgensen; C Filipe Pereira; Marion Leleu; Francesco M Piccolo; Mikhail Spivakov; Emily Brookes; Ana Pombo; Cynthia Fisher; William C Skarnes; Tim Snoek; Karel Bezstarosti; Jeroen Demmers; Robert J Klose; Miguel Casanova; Ligia Tavares; Neil Brockdorff; Matthias Merkenschlager; Amanda G Fisher
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

Review 10.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

View more
  61 in total

Review 1.  Regulation of mammary epithelial cell homeostasis by lncRNAs.

Authors:  Amy N Shore; Jeffrey M Rosen
Journal:  Int J Biochem Cell Biol       Date:  2014-03-26       Impact factor: 5.085

2.  lincRNA HOTAIR as a novel promoter of cancer progression.

Authors:  Gregory Loewen; Ying Zhuo; Yan Zhuang; Janarthanan Jayawickramarajah; Bin Shan
Journal:  J Can Res Updates       Date:  2014-07

Review 3.  Long non-coding RNA HOTAIR in carcinogenesis and metastasis.

Authors:  Jinsong Zhang; Peijing Zhang; Li Wang; Hai-long Piao; Li Ma
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-10-27       Impact factor: 3.848

Review 4.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

5.  EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis.

Authors:  Yu Zhao; Liya Ding; Dejie Wang; Zhenqing Ye; Yundong He; Linlin Ma; Runzhi Zhu; Yunqian Pan; Qiang Wu; Kun Pang; Xiaonan Hou; Saravut J Weroha; Conghui Han; Roger Coleman; Ilsa Coleman; R Jeffery Karnes; Jun Zhang; Peter S Nelson; Liguo Wang; Haojie Huang
Journal:  EMBO J       Date:  2019-02-05       Impact factor: 11.598

6.  Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.

Authors:  Xiaokun Gang; Guixia Wang; Haojie Huang
Journal:  Prostate       Date:  2015-01-28       Impact factor: 4.104

7.  AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.

Authors:  Chun-Wu Pan; Xin Jin; Yu Zhao; Yunqian Pan; Jing Yang; R Jeffrey Karnes; Jun Zhang; Liguo Wang; Haojie Huang
Journal:  EMBO J       Date:  2017-03-09       Impact factor: 11.598

8.  The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.

Authors:  Woo Kyun Bae; Kyung Hyun Yoo; Ji Shin Lee; Young Kim; Ik-Joo Chung; Min Ho Park; Jung Han Yoon; Priscilla A Furth; Lothar Hennighausen
Journal:  Mol Carcinog       Date:  2014-07-07       Impact factor: 4.784

9.  MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.

Authors:  Magdalena Wienken; Antje Dickmanns; Alice Nemajerova; Daniela Kramer; Zeynab Najafova; Miriam Weiss; Oleksandra Karpiuk; Moustapha Kassem; Yanping Zhang; Guillermina Lozano; Steven A Johnsen; Ute M Moll; Xin Zhang; Matthias Dobbelstein
Journal:  Mol Cell       Date:  2015-12-31       Impact factor: 17.970

10.  Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer.

Authors:  Ting-Hua Yan; Sui-Wan Lu; Yong-Qing Huang; Gan-Bo Que; Jun-Hui Chen; Yong-Ping Chen; Hong-Bin Zhang; Xing-Lan Liang; Jin-Hua Jiang
Journal:  Tumour Biol       Date:  2014-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.